Answers are grounded in this paper and cite their sources.
Our results clearly indicate a great potential of the NAT2 genotype-guided dosing stratification of isoniazid in chemotherapy for tuberculosis.
No takes yet. Share an insight, caveat, or question.
Azuma et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: